|
Re: Lu stepping down
|
2
|
Resverlogix Corp.
|
Feb 24, 2024 04:39PM
|
|
Re: Response - opp next agm? Brutal imo
|
4
|
Resverlogix Corp.
|
Feb 27, 2024 10:05AM
|
|
Re: More Exempt Distribution Investments
|
4
|
Zenith Epigenetics
|
Feb 29, 2024 10:38AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
4
|
Zenith Epigenetics
|
Feb 29, 2024 11:09AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
4
|
Zenith Epigenetics
|
Mar 01, 2024 07:04AM
|
|
Re: Zenith Epigenetics Proudly Supports Rare Disease Day ZEN-3694 Expands Development to Include Multiple Rare Oncology Indications Calgary, Alberta--(N
|
5
|
Zenith Epigenetics
|
Mar 01, 2024 01:25PM
|
|
Pfizer lays out ambitious vision for cancer portfolio in bid to reinvigorate its business.
|
6
|
Zenith Epigenetics
|
Mar 01, 2024 07:09PM
|
|
Canada RVX TSX/CA Resverlogix Corp. 0.055 CAD -0.005 (-8.33%).
|
1
|
Resverlogix Corp.
|
Mar 04, 2024 10:07AM
|
|
Re: Short report
|
2
|
Resverlogix Corp.
|
Mar 04, 2024 10:11AM
|
|
Re: A Bio investor must
|
2
|
Resverlogix Corp.
|
Mar 04, 2024 01:54PM
|
|
Re: Pfizer
|
3
|
Zenith Epigenetics
|
Mar 11, 2024 10:20AM
|
|
Re: Little confused, any insight would be great
|
6
|
Resverlogix Corp.
|
Mar 11, 2024 12:50PM
|
|
Re: Little confused, any insight would be great
|
2
|
Resverlogix Corp.
|
Mar 11, 2024 05:57PM
|
|
Re: Pfizer
|
3
|
Zenith Epigenetics
|
Mar 12, 2024 01:45PM
|
|
Re: Little confused, any insight would be great
|
1
|
Resverlogix Corp.
|
Mar 13, 2024 03:16PM
|
|
Canadian Investment Regulatory Organization Trading Halt - BTI 2 hours ago
|
1
|
BIOASIS TECHNOLOGIES INC
|
Mar 21, 2024 09:28AM
|
|
Re: Annual Financial Reporting
|
3
|
Resverlogix Corp.
|
Apr 02, 2024 08:52AM
|
|
Re: Next question
|
2
|
Resverlogix Corp.
|
Apr 02, 2024 04:53PM
|
|
Re: Next question
|
2
|
Resverlogix Corp.
|
Apr 02, 2024 06:25PM
|
|
Re: Next question
|
2
|
Resverlogix Corp.
|
Apr 03, 2024 08:31AM
|
